The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia
Open accessAbstract
Ebola virus disease (EVD) developed in a patient who contracted the disease in Sierra Leone and was airlifted to an isolation facility in Hamburg, Germany, for treatment. During the course of the illness, he had numerous complications, including septicemia, respiratory failure, and encephalopathy. Intensive supportive treatment consisting of high-volume fluid resuscitation (approximately 10 liters per day in the first 72 hours), broad-spectrum antibiotic therapy, and ventilatory support resulted in full recovery without the use of experimental therapies. Discharge was delayed owing to the detection of viral RNA in urine (day 30) and sweat (at the last assessment on day 40) by means of polymerase-chain-reaction (PCR) assay, but the last positive culture was identified in plasma on day 14 and in urine on day 26. This case shows the challenges in the management of EVD and suggests that even severe EVD can be treated effectively with routine intensive care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections
WHO Ebola Response Team (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411100 · Cited by 1,674
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366
Self-citationThe International Ebola Emergency
Briand, S., Bertherat, E., Cox, P., Formenty, P., Kieny, M.-P., Myhre, J. K., Roth, C., Shindo, N., & Dye, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1409858 · Cited by 240
Parenteral glutamine supplementation in critical illness: a systematic review
Wischmeyer, P. E., Dhaliwal, R., McCall, M., Ziegler, T. R., & Heyland, D. K. (2014) · Critical Care · doi:10.1186/cc13836 · Cited by 175
Immunopathology of highly virulent pathogens: insights from Ebola virus
Zampieri, C. A., Sullivan, N. J., & Nabel, G. J. (2007) · Nature Immunology · doi:10.1038/ni1519 · Cited by 146
The Ebola Emergency — Immediate Action, Ongoing Strategy
Farrar, J., & Piot, P. (2014) · New England Journal of Medicine · doi:10.1056/nejme1411471 · Cited by 140
Doing Today's Work Superbly Well — Treating Ebola with Current Tools
Lamontagne, F., Clément, C., Fletcher, T. E., Jacob, S. T., Fischer, W. A., & Fowler, R. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1411310 · Cited by 98
Cited by
Recognition of aerosol transmission of infectious agents: a commentary
Tellier, R., Li, Y., Cowling, B. J., & Tang, J. W. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3707-y · Cited by 746
Malvy, D., McElroy, A. K., de Clerck, H., Günther, S., & van Griensven, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33132-5 · Cited by 419
Self-citationThe Pathogenesis of Ebola Virus Disease
Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100506 · Cited by 404
Clinical Management of Ebola Virus Disease in the United States and Europe
Uyeki, T. M., Mehta, A. K., Davey, R. T., Liddell, A. M., Wolf, T., Vetter, P., Schmiedel, S., Grünewald, T., Jacobs, M., Arribas, J. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504874 · Cited by 368
Self-citationDrug repurposing for antimicrobial discovery
Farha, M. A., & Brown, E. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0357-1 · Cited by 360
Metadata
- Authors
- Kreuels, B., Wichmann, D., Emmerich, P., Schmidt-Chanasit, J., de Heer, G., Kluge, S., Sow, A., Renné, T., Günther, S., Lohse, A. W., Addo, M. M., & Schmiedel, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-12-18
- Volume
- 371
- Issue
- 25
- Pages
- 2394-2401
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2140352666
- Cited by
- 302
- References
- 7
- FWCI
- 42.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.